Legal support for the participation of volunteers (volunteers) in clinical trials of the efficacy and safety of immunobiological drugs

Author:

Kholopova E. N,Goncharov A. G,Pestrikova A. A,Litvinova L. S

Abstract

In modern realities, medicine is an object of close attention, both from regulatory organizations and from social media. In such conditions of constant monitoring and pressure, clinical trials of newly developed immunobiological drugs (IBD) require effective legal support for all stages of the trials, as well as proper legal protection of volunteers in clinical trials of the effectiveness and safety of IBD, taking into account all possible risks. In the presented review, the Russian and foreign experience of legal support of this sphere of public relations is studied using the example of a vaccine against coronavirus infection, as well as proposals for its improvement.

Publisher

ECO-Vector LLC

Subject

Transplantation,Cell Biology,Molecular Biology,Biomedical Engineering,Surgery,Biotechnology

Reference49 articles.

1. Федеральный закон от 12.04.2010 № 61-ФЗ «Об обращении лекарственных средств». Справочная правовая система «Гарант».

2. Национальный стандарт Российской Федерации (ГОСТ Р. 523792005) «Надлежащая клиническая практика».

3. Распоряжение Правительства РФ от 18 сентября 2020 г. № 2390-р «Об утверждении Стратегии развития иммунопрофилактики инфекционных болезней на период до 2035 года». Справочная правовая система «Гарант».

4. Committee for medicinal product for human use, London, Doc. Ref. EMEA/CHMP/410869/2006, 2008, https:/www.ema.europa.eu/en/documents/scientific-guideline/guideline-human-cell-based-medicinal-products_en.pdf.

5. Directive 98/44/EC of the European parliament and of the council. Official Journal of the European Communities. OJ. 1998; L213: 13, http:/en.academic.ru/dic.nsf/enwiki/776654.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3